Table 4

Univariate analysis of comparing reoperation versus no-reoperation within 12 months following revision ankle replacement surgery

12 months following revision ankle replacement
ReoperationNo-reoperation
Agen (proportion)n (proportion)OR (95% CI, p value)
 <652 (0.29)34 (0.5)Ref
 65–744 (0.57)19 (0.28)3.5 (0.4 to 40, p=0.2)
 >751 (0.14)15 (0.22)1.1 (0.01 to 22, p=0.1)
Length of staymean (range)mean (range)
3.6 (1-6)4.3 (1–12)p=0.78
BMIn (proportion)n (proportion)OR (95% CI, p value)
 Underweight1 (0.25)0 (0)
 Normal1 (0.25)5 (0.14)Ref
 Overweight2 (0.5)30 (0.86)0.3 (0.02 to 24, p=0.41)
Missing=36
Gender/F43%44%
Operationn (proportion)n (proportion)OR (95% CI, p value)
 Uncemented TAR2 (0.5)38 (0.78)Ref
 Hybrid1 (0.25)9 (0.18)2.1 (0.3 to 44, p=0.5)
 TTC nail1 (0.25)2 (0.04)9.5 (0.1 to 250, p=0.2)
Missing=22
ASAn (proportion)n (proportion)OR (95% CI, p value)
 1–22 (0.29)14 (0.21)Ref
 3–45 (0.71)54 (0.79)0.7 (0.1 to 11, p=0.64)
Charlsonn (proportion)n (proportion)
 07 (1.0)67 (0.98)
 10 (0)1 (0.02)
 20 (0)0 (0)
  • ASA, American Society of Anesthesiologists; BMI, body mass index; CI, confidence interval; F, female; n, number of patients NHS, national health service; OR, odds ratio; Ref, reference value; SD, standard deviation; TTC, Tibio-Talar-Calcaneal.